<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528449</url>
  </required_header>
  <id_info>
    <org_study_id>BNATIFA-10</org_study_id>
    <nct_id>NCT01528449</nct_id>
    <nct_alias>NCT01525030</nct_alias>
  </id_info>
  <brief_title>Babesia Testing in Blood Donors</brief_title>
  <official_title>Blood Donation Screening for Babesia Microti by Real-time Polymerase Chain Reaction (PCR) and by Indirect Flourescent Antibody (IFA) Assays</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imugen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American National Red Cross</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Memorial Blood Centers, Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rhode Island Blood Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imugen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Both prospective and retrospective (look back) study of blood donors for laboratory evidence
      of babesia microti infection.

      Two laboratory methodologies will be utilized:

        1. - PCR, to look for the presence of B.microti in whole blood

        2. - IFA, to look for significant titers of B.microti antibody
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective study will involve archived specimens from blood donors whose units have
      already been released and transfused into recipients.

      Prospective study will be real time and units testing positive by either PCR or IFA will be
      not released and will be disgarded, and the donors advised and deferred from further blood
      donation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of blood donors testing positive for evidence of Babesia infection</measure>
    <time_frame>goal is up to one year (all specimens by end 2012)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number of cases of transfusion transmitted babesia infection identified</measure>
    <time_frame>goal is up to one year (all specimens by end 2012)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90116</enrollment>
  <condition>Transfusion Transmitted Babesiosis</condition>
  <arm_group>
    <arm_group_label>retrospective</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>archived specimens from blood donors whose units have already been released and transfused into recipients will be tested. Attempts will be made to contact and obtain follow up specimens from both the donor and recipient of units initially testing positive for B.microti. the interventions are investigational diagnostic tests for B.microti (PCR and IFA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prospective, real time</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>specimens from current blood donors will be tested and those testing positive for B.microti will not be released and the units will be disgarded, and the donors notified and deferred from future blood donation. the interventions are investigational diagnostic tests for B.microti (PCR and IFA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>B.microti diagnostic blood tests</intervention_name>
    <description>the interventions/procedures are investigational diagnostic tests for B.microti (PCR and IFA).</description>
    <arm_group_label>retrospective</arm_group_label>
    <other_name>proprietary in-house developed PCR and IFA Babesia doagnostic tests</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>B.microti diagnostic blood tests</intervention_name>
    <description>the interventions/procedures are investigational diagnostic tests for B.microti (PCR and IFA).</description>
    <arm_group_label>prospective, real time</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  same as for donating blood

        Exclusion Criteria:

          -  donor refusual to sign informed consent for this investigational babesia testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip J Molloy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imugen Medical Director</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imugen</name>
      <address>
        <city>Norwood</city>
        <state>Massachusetts</state>
        <zip>02062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2012</study_first_submitted>
  <study_first_submitted_qc>February 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>babesia</keyword>
  <keyword>blood donation</keyword>
  <keyword>transfusion transmitted babesiosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Babesiosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

